Skip to main content
Hirva Mamdani, MD, Oncology, Detroit, MI

HirvaMansuraliMamdaniMD

Oncology • Detroit, MI

Thoracic Cancer

Medical Oncology, Karmanos Cancer Institute. Assistant Professor of Medicine, Wayne State University

Join to view full profile

Dr. Mamdani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mamdani's full profile

Already have an account?

  • Office

    4100 John R St
    Detroit, MI 48201
    Phone+1 313-576-8709

Summary

  • Dr. Hirva Mamdani is a medical oncologist specializing in treatment of thoracic malignancies, including lung cancer, mesothelioma, and esophageal cancer. She is affiliated with Karmanos Cancer Institute - an NCI designated comprehensive cancer center. Dr. Mamdani received her medical degree from M.P. Shah Medical College in India. She completed her residency from Wayne State University, Detroit MI and fellowship training from Indiana University, Indianapolis IN. Dr. Mamdani is involved in a large number of national and global clinical trials evaluating novel therapeutic agents for the treatment of thoracic cancers. Her areas of research interest include immunotherapy and DNA repair pathways.

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2014 - 2017
  • Detroit Medical Center/Wayne State University
    Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 2011 - 2014
  • M.P. Shah Medical College
    M.P. Shah Medical CollegeClass of 2009

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2016 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Young Investigator Award Immunooncology Young Investigators’ Forum, 2019
  • Young Investigator Award Young Investigators’ Forum in Lung Cancer, 2019

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Safety and efficacy of durvalumab following multimodality therapy for locally advanced esophageal and GEJ adenocarcinoma: Two-year follow-up results from Big Ten Cance... 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
  • A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination (HR) defective or loss of heterozygosity (LOH... 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
  • Safety and efficacy of durvalumab following multimodality therapy for locally advanced esophageal and GEJ adenocarcinoma: Results from big ten cancer research consorti... 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
  • Join now to see all

Press Mentions

  • Karmanos Cancer Institute Recognizes Lung Cancer Awareness Month, Encourages Screenings
    Karmanos Cancer Institute Recognizes Lung Cancer Awareness Month, Encourages ScreeningsNovember 4th, 2024
  • Early Detection Is Key for This Common Form of Cancer
    Early Detection Is Key for This Common Form of CancerNovember 21st, 2022
  • Karmanos Cancer Institute Partners with Nation's Top Cancer Organizations to Endorse Initiative to Increase Lung Cancer Screening in the United States
    Karmanos Cancer Institute Partners with Nation's Top Cancer Organizations to Endorse Initiative to Increase Lung Cancer Screening in the United StatesNovember 1st, 2022
  • Join now to see all

Professional Memberships

Other Languages

  • Hindi, Gujarati

Dr. Hirva Mamdani, Dr. Hirva Mamdani, MD, Dr. H Mamdani, Dr. Hirva Mansurali Mamdani